Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Let us help you
Read about the latest topics.

Accreditation Certification ISQua EEA

 
The Ministry of Public Health (MOPH) is proud to announce the reception of the prestigious Award by the International Society for Quality in Health Care – External Evaluation Association (ISQua EEA) for the Accreditation Standards of Hospitals in Lebanon 2022 Edition.

This development marks a crucial step forward for quality improvement and the enhancement of patient safety culture with internationally recognized standards.

Given the principal importance of improving healthcare management, quality of care, and patient safety in our hospitals, especially in these challenging times in Lebanon, we are committed to maintaining the accreditation process as an integral part of continuous healthcare improvement in Lebanon, with teams/trainers dedicated to improving care in hospitals, 44 trained surveyors and more than 500 health professionals from all hospitals in Lebanon currently being trained.

Special recognition goes to Dr. Walid Ammar for his leadership and guidance in transforming the hospital accreditation system in Lebanon.

We would like to extend our gratitude to Dr. Fadi El-Jardali and his team for their exceptional work in revising and improving the accreditation standards and tools. We also thank Dr. Ali Elhaj for his contributions during the initial phase of standards revision.

We are deeply grateful the financial support of AFD, to the Haute Autorité de Santé (HAS France) and all individuals who offered their advice and technical support, especially Dr. Bruno Lucet for his complete support during all the preparation process for the ISQua EEA certification.

We express our sincere appreciation to the Comité Technique d’Accréditation Hospitalière (CTAH) for their valuable feedback and suggestions, as well as the National Hospital Accreditation Committee (CNAH) including the main stakeholders: Ecole Supérieure des Affaires (ESA), Syndicate of Hospitals, Order of Physicians, Order of Nurses, Order of Pharmacists, Order of Midwives, Lebanese National Committee of Blood Transfusion, Army Medical Services, NSSF, MFE, and various faculties of medicine. We would like to acknowledge their contributions and their unwavering support.

Additionally, we extend our warm thanks to the national experts for their invaluable feedback and suggestions on the standards.

A special thanks to Perrine Malaud Wakim and the team of Pôle Santé at for their continuous dedication and support.

#Healthcare #Quality #Accreditation #Standards # Patient Safety Culture #MOPH #ESA #AFD #HAS #CNAH #CTAH #
    5
ATC Name B/G Ingredients Dosage Form Price
R06AX ORADUS BETA G Desloratadine - 1mg/ml, Betamethasone - 0.05mg/ml Solution 639,925 L.L
R06AX27 ORADUS G Desloratadine - 0.5mg/ml 0.5mg/ml Solution 199,657 L.L
A04AA01 ONDEMED G Ondansetron (HCl) - 4mg/5ml 4mg/5ml Solution 858,779 L.L
S01BA07 OPTILONE G Fluorometholone - 0.1% 0.1% Solution 309,084 L.L
R01AD08 OTRIALLERGY B Fluticasone propionate - 50mcg/actuation 50mcg/actuation Spray, suspension 675,953 L.L
G01AX OVUMIX G Metronidazole - 300mg, Miconazole - 100mg, Neomycin (sulfate) - 48.8mg, Gotu Kola - 15mg, Polymixin sulfate - 4.4mg Suppository 395,090 L.L
A10BH03 ONGLYZA B Saxagliptin HCl - 2.5mg 2.5mg Tablet 1,987,543 L.L
N05AH03 OLANZAMED G Olanzapine - 5mg 5mg Tablet 665,522 L.L
A10BH03 ONGLYZA B Saxagliptin HCl - 5mg 5mg Tablet 3,836,670 L.L
N05AH03 OLANZAPINE ARROW G Olanzapine - 5mg 5mg Tablet 670,577 L.L
N05AH03 OLANZAMED G Olanzapine - 20mg 20mg Tablet 3,941,938 L.L
N05AH03 OLANZAMED G Olanzapine - 10mg 10mg Tablet 902,294 L.L
N05AH03 OLANZAPINE ARROW G Olanzapine - 10mg 10mg Tablet 822,432 L.L
N05AH03 OLANZAPINE ARROW G Olanzapine - 7.5mg 7.5mg Tablet 822,432 L.L
A12AX OSTRONG G Vitamin D3 - 500IU, Calcium hydrogen phosphate - 600mg Tablet 435,149 L.L
A10BB12 ORBIDE G Glimepiride - 1mg 1mg Tablet 207,336 L.L
A10BB12 ORBIDE G Glimepiride - 2mg 2mg Tablet 209,895 L.L
A10BB12 ORBIDE G Glimepiride - 3mg 3mg Tablet 351,959 L.L
C09AA01 ORBACE G Captopril - 25mg 25mg Tablet 522,179 L.L
A10BB12 ORBIDE G Glimepiride - 4mg 4mg Tablet 357,078 L.L
C09AA01 ORBACE G Captopril - 50mg 50mg Tablet 949,649 L.L
A10BD02 ORBIZIDE M FORTE G Metformin HCl - 500mg, Gliclazide - 80mg Tablet 771,750 L.L
C10AA05 ORBALIP G Atorvastatin (calcium) - 10mg 10mg Tablet 966,287 L.L
C10AA05 ORBALIP G Atorvastatin (calcium) - 20mg 20mg Tablet 1,091,712 L.L
N05AG02 ORAP FORTE B Pimozide - 4mg 4mg Tablet 329,241 L.L
C10AA05 ORBALIP G Atorvastatin (calcium) - 40mg 40mg Tablet 1,405,275 L.L
M05BA04 OREK G Alendronate - 70mg 70mg Tablet, coated 2,404,838 L.L
N06AB03 OXETINE 20 G Fluoxetine (HCl) - 20mg 20mg Tablet, coated 362,837 L.L
A04AA01 ONDANSETRON BIOGARAN G Ondansetron - 8mg 8mg Tablet, coated 1,307,559 L.L
A02BC01 OMEDAR G Omeprazole - 20mg 20mg Tablet, enteric coated 18,087,352 L.L
    5
Sitemap
© Copyrights reserved to Ministry of Public Health 2025